Generation Wellness to a Global Audience with Multilingual, Accessible AI Solutions MESA, ARIZONA / ACCESS Newswire / November 3, 2025 / Medical Care Technologies, Inc. (OTC Pink:MDCE) is excited to ...
Dr. Naderi reveals how younger generations are embracing prejuvenation with collagen-boosting treatments and skincare to maintain a natural, youthful glow before aging signs appear. RESTON, VA / ...
LUND, SE / ACCESS Newswire / November 3, 2025 / BioInvent International AB ("BioInvent")(STO:BINV)(Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and first ...
CID-103 is a potential best-in-class, anti-CD38 monoclonal antibody- Phase 1 dose escalation study in Immune Thrombocytopenia (ITP) results and update SOUTH SAN FRANCISCO, CA / ACCESS Newswire / ...
UPPSALA, SWEDEN / ACCESS Newswire / November 3, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - A Nomination Committee consisting of shareholder representatives has been established for Senzime AB (publ.) in ...
Demonstrated feasibility of effective DNA delivery with Company's xPhore™ nanoparticle technologyDNA delivery technology to be offered as GenePhore™ to biotech / pharma companiesAddressing large and ...
LUND, SWEDEN / ACCESS Newswire / November 3, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX), a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs, ...
LUND, SE / ACCESS Newswire / November 3, 2025 / BioInvent International AB ("BioInvent") (STO:BINV)(Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and ...
The hazard ratio (HR) for the primary endpoint was (3.84, p = 0.0009) in the first monthThe Prolocor pFCG™ test has the potential to help providers reduce 30-day readmission rates for Acute MI, ...
Biohope Announces Collaboration to Advance Immunobiogram Diagnostic Solution to Optimize Immunosuppression Therapy for Transplant Patients MADRID, ES / ACCESS Newswire / November 3, 2025 / Biohope, a ...
Company Extending Warranty as a Promise of Quality and a Thank You to Customers. SALT LAKE CITY, UTAH / ACCESS Newswire / November 3, 2025 / To show Hoggan Scientific's ongoing commitment to customer ...
Modular Medical Announces Successful Validation of Controller Line for Pivot Insulin Delivery System
Manufacturing line has now been validated for human-use production in support of expected Q1 2026 market launch.Pivot will be First Two-Part Tubeless Patch Pump: Pivot, a 3 milliliter removable patch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback